ABC | Volume 110, Nº5, Maio 2018

Artigo de Revisão Ybarra et al ICP em CTO Arq Bras Cardiol. 2018; 110(5):476-483 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 47. Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (Outcomes, Patient Health Status, and Efficiency inChronic Total OcclusionHybrid Procedures). JACC Cardiovasc Interv. 2017;10(15):1523-34. 48. Brilakis ES, Banerjee S, Karmpaliotis D, Lombardi WL, Tsai TT, Shunk KA, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8(2):245-53. 49. Stetler J, Karatasakis A, Christakopoulos GE, Tarar MN, Amsavelu S, Patel K, et al. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2016;88(1):1-6. 50. DiSerafinoL,BorgiaF,Maeremans J,PyxarasSA,DeBruyneB,WijnsW,etal. Periprocedural myocardial injury and long-termclinical outcome in patients undergoing percutaneous coronary interventions of coronary chronic total occlusion. J Invasive Cardiol. 2016;28(10):410-4. 51. Jang WJ, Yang JH, Choi SH, Song YB, Hahn JY, Kim WS, et al. Association of periprocedural myocardial infarction with long-term survival in patients treated with coronary revascularization therapy of chronic total occlusion. Catheter Cardiovasc Interv. 2016;87(6):1042-9. 52. Lo N, Michael TT, Moin D, Patel VG, Alomar M, Papayannis A, et al. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study. JACC Cardiovasc Interv. 2014;7(1):47-54. 53. Ojeda S, Pan M, Gutierrez A, Romero M, Chavarria J, de Lezo JS, et al. Bifurcation lesions involved in the recanalization process of coronary chronic total occlusions: incidence, treatment and clinical implications. Int J Cardiol. 2017;230:432-8. 54. Nguyen-Trong PK, Rangan BV, Karatasakis A, Danek BA, Christakopoulos GE, Martinez-Parachini JR, et al. Predictors and outcomes of side-branch occlusion in coronary chronic total occlusion interventions. J Invasive Cardiol. 2016;28(4):168-73. 55. Werner GS. A Randomized multicentre trial to evaluate the utilization of revascularization or optimal medical therapy for the treatment of chronic total coronary occlusions (EuroCTO). Euro PCR Abstracts. Paris (France); 2017. 56. Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994;90(6):2725-30. 57. Christakopoulos GE, Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, et al. Predictors of excess patient radiation exposure during chronic total occlusion coronary intervention: insights froma contemporary multicentre registry. Can J Cardiol. 2017;33(4):478-84. 58. Balter S, Brinkman M, Kalra S, Nazif T, Parikh M, Kirtane AJ, et al. Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions. EuroIntervention. 2017;13(12):e1468-e1474. 59. YbarraLF,DautovR,GibratC,DandonaS,RinfretS.Mid-termangina-related quality of life benefits after percutaneous coronary intervention of chronic total occlusions. Can J Cardiol. 2017;33(12):1668-74. 60. Mashayekhi K, Neuser H, Kraus A, Zimmer M, Dalibor J, Akin I, et al. Successful percutaneous coronary intervention improves cardiopulmonary exercise capacity in patients with chronic total occlusions. J AmColl Cardiol. 2017;69(8):1095-6. 61. Jang WJ, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion andwell-developed collateral circulation. JACC Cardiovasc Interv. 2015;8(2):271-9. 62. Tomasello SD, Boukhris M, Giubilato S, Marza F, Garbo R, ContegiacomoG, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36(45):3189-98. 63. Henriques JP, Hoebers LP, Ramunddal T, Laanmets P, Eriksen E, Bax M, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68(15):1622-32. 64. Park S-J. Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO). American College of Cardiology’s 66th Annual Scientific Session& Expo;Washington, DC, USA2017. 65. Gao L, Wang Y, Liu Y, Cao F, Chen Y. Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2017;89(S1):574-81. 66. Hannan EL, Zhong Y, Jacobs AK, Stamato NJ, Berger PB, Walford G, et al. Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions:Characteristics,Success,andOutcomes.Circulation Cardiovascular interventions. 2016;9(5):e003586. 483